Role of 90K/Mac-2 BP as an Indicator of Early Response to Infliximab Therapy in IBD Patients
Clinical trial NCT05960162 · UNKNOWN
Trial details
- NCT number
- NCT05960162
- Sponsor
- Assiut University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-17
- Primary completion
- 2024-07-17
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.